Medical Research
Thank You USCAP 2016 from PathXL
PathXL would like to thank the organisers of USCAP, everyone that stopped by Stand #1119 and in particular the attendees of our inaugural USA Usergroup on Sunday 13th March. We received some amazing interest on PathXL’s Xplore and TissueMark...
Visiopharm Powers Up With VIS 6.0
Visiopharm, the leading provider of quantitative digital pathology software for diagnostics and research, announces the launch of VIS 6.0-- a powerful new version of their software. VIS 6.0 includes many new features plus Engine™ a new...
Register Now For DigitalPath Europe 2016 – London, May 18-19
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Digital Pathology News
- Education
- Electronic Medical Records
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- TeleHealth
- Training
- Vendor products
- Web/Tech
- Whole slide
18-19 May 2016 Hilton Tower Bridge London http://bit.ly/1LCxPgg The DigitalPath Europe Congress will review the game changing innovation, roadblocks and critical success factors in the utilisation of digital in pathology. Key highlights...
Congratulations to Dr. Hamilton and the team at PathXL on this patent. Look for more patents to be granted to PathXL in the future. There is a perfect storm brewing right now in digital pathology -- goals for precision medicine, image...
Cynvenio Biosystems, Inc., a diagnostics company dedicated to enabling the new era of individualized medicine for all cancer patients, recently announced the availability of the ConcordiaT cell-free DNA (cfDNA) purification sample...
I saw an article late last month before the ink was dry on the Executive Order and budget increase requests citing “the Vice President’s call for a cancer moonshot has struck a deep nerve in the research community as scientists blame the...































